Medical News

RSS

Lumizyme receives FDA approval for patients with late-onset Pompe disease

The U.S. Food and Drug Administration approved Lumizyme (alglucosidase alfa) for patients ages 8 years and older with late-onset (non-infantile) Pompe disease, a rare genetic disorder.

26 May 2010

Heptares Therapeutics, O2h extend multi-FTE -synthetic chemistry services collaboration

Executives from Heptares Therapeutics (Welwyn Garden City, UK) and O2h (Cambridge, UK) announced today an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.

26 May 2010

Penn. doc creates medical home as part of health care transformation

The Philadelphia Inquirer reports on Joseph Mambu, a Pennsylvania doctor who created a medical home in 2001. At the beginning "Mambu didn't know where he was headed. Now he's at the vanguard of a movement sweeping America - the patient-centered medical home - in which physicians have more time for complex cases and are much more proactive in promoting the health of all patients, who have same-day access to their medical team."

26 May 2010

Researchers examine association between use of antibiotics and outcomes among patients with COPD

Among patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease, those who received antibiotics in the first 2 hospital days had improved outcomes, such as a lower likelihood of mechanical ventilation and fewer readmissions, compared to patients who received antibiotics later or not at all, according to a study in the May 26 issue of JAMA.

26 May 2010

Spouses face hurdles when caring for themselves, ill loved ones

Reporting for Kaiser Health News, in collaboration with The Washington Post, Paula Span writes: "They met on a blind date in 1949 and married two years later.

26 May 2010

Mesa Laboratories fourth-quarter net sales up 14% to $6.23 million

Mesa Laboratories, Inc. today reported record sales results for the quarter and year ended March 31, 2010.

26 May 2010

Accretive Health closes initial public offering of common stock

Accretive Health, Inc., a leading provider of end-to-end revenue cycle management services for U.S. healthcare providers, today announced it has closed its previously announced initial public offering of 11,500,000 shares of its common stock at a price to the public of $12.00 per share.

26 May 2010

Kidney Health Week, experts criticise government inaction

Kidney Health Week is being observed at Broken Hill Hospital this week by the Broken Hill Health Service. As a part of this the residents will receive complete kidney check ups including blood pressure and blood sugar and advice regarding kidney health.

26 May 2010

Genzyme's suit stays final FDA approval of Watson's generic Renvela ANDA

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market sevelamer carbonate 800mg tablets. Watson's sevelamer carbonate tablet is the generic version of Genzyme's Renvela®. Renvela ® is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease who are on dialysis.

26 May 2010

Benefit Advocates launches its redesigned website

Benefit Advocates Inc. recently launched its redesigned website at www.benefitadvocates.net. The new design offers visitors ease of use and comprehensive information on Benefit Advocates' company profile, employer and broker services, and healthcare industry perspectives.

26 May 2010

Health law bodes well for young people's coverage, isn't helping Democrats

The New York Times reports that young people — representing nearly one-third of the 46 million uninsured in America — stand to "reap substantial benefits" from expanded coverage for them in the new health law.

26 May 2010

State Roundup: Oklahoma, S.C. and Ill. facing tough choices on health costs

States around the country are debating how to deal with health costs and tight budgets.

26 May 2010

AAHSA applauds Sen. Russ Feingold for introducing the Improving Quality of Care in Nursing Homes Act

The American Association of Homes and Services for the Aging's President and CEO Larry Minnix applauds Sen. Russ Feingold (D-Wisc.) for introducing the Improving Quality of Care in Nursing Homes Act.

26 May 2010

GTx reports top line results from toremifene Phase III clinical trial for prostate cancer

GTx, Inc. today announced top line results of the Phase III clinical trial evaluating toremifene 20 mg, a selective estrogen receptor modulator, for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, or PIN, a premalignant lesion of the prostate.

26 May 2010

Dangerous bacterium appears in Australia for the first time

Clostridium difficile is a bacterium that has killed thousands abroad. Now is has been detected in three Australians for the first time. The bacterium was detected in three patients at Melbourne's Epworth Hospital.

25 May 2010

Pioneers Memorial Healthcare District purchases QuadraMed CPR EHR solution

QuadraMed® Corporation today announced that Pioneers Memorial Healthcare District in Brawley, Calif., has selected the QuadraMed CPR (QCPR™) electronic health record (EHR) solution and several other QuadraMed applications to help improve the quality of patient care, increase operational efficiencies and enhance revenues. Also included in the purchase are QuadraMed's identity management, enterprise scheduling, revenue management and nurse-staffing management solutions.

25 May 2010

UnitedHealth shareholders reject plan to weigh in on executive pay

A proposal to allow UnitedHealth Group shareholders to make suggestions about executive pay was voted down by the same shareholders it would have empowered at the firm's annual meeting Monday, the Minneapolis Star Tribune reports. The proposal failed with only forty-six percent of shareholders supporting it.

25 May 2010

Mylan Pharmaceuticals introduces Temazepam Capsules USP, 7.5 mg

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Temazepam Capsules USP, 7.5 mg.

25 May 2010

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.

25 May 2010